QUANTIFICATION OF APOLIPOPROTEIN A-IV IN HUMAN PLASMA BY IMMUNONEPHELOMETRY

被引:0
|
作者
SCHWARZ, S
HAAS, B
LULEY, C
SCHAFER, JR
STEINMETZ, A
机构
[1] UNIV MARBURG,ZENTRUM INNERE MED,ENDOKRINOL & STOFFWECHSEL ABT,D-35033 MARBURG,GERMANY
[2] UNIV FREIBURG,KLIN CHEM ABT,D-79106 FREIBURG,GERMANY
关键词
LIPOPROTEINS; ATHEROSCLEROSIS; ELECTROIMMUNODIFFUSION COMPARED; TRIGLYCERIDES; SAMPLE HANDLING;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We developed a nephelometric procedure for determining concentrations of human plasma apolipoprotein (ape) A-IV. Results obtained correlate well with those measured by an established electroimmunodiffusion assay (r = 0.98; n = 56). Intra- and interassay CVs were 2.4% and 2.0%, respectively, indicating excellent precision and reproducibility. Various conditions of sample treatment, such as adequate storage, freezing, and thawing, did not affect results significantly. However, keeping samples at room temperature for 4 days led to a slight increase in measured values. Preincubation with a cholesterinesterase-detergent mixture abolished interference from triglyceride-rich lipoproteins, allowing assay of samples containing triglycerides as great as 10 g/L. The assay is easily applicable to clinical laboratories for routine diagnostic use, as shown with hypertriglyceridemic plasmas and samples with a broad range of apo A-IV concentrations.
引用
收藏
页码:1717 / 1721
页数:5
相关论文
共 50 条
  • [1] HUMAN APOLIPOPROTEIN A-IV
    BOVARDHOUPPERMANS, S
    ANNALES DE BIOLOGIE CLINIQUE, 1994, 52 (10) : 701 - 710
  • [2] CHARACTERIZATION OF APOLIPOPROTEIN A-IV COMPLEXES AND A-IV ISOFORMS IN HUMAN LYMPH AND PLASMA-LIPOPROTEINS
    OHTA, T
    FIDGE, NH
    NESTEL, PJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1984, 259 (23) : 4888 - 4893
  • [3] MOLECULAR-BASIS FOR HUMAN PLASMA APOLIPOPROTEIN A-IV POLYMORPHISM
    LOHSE, P
    KINDT, MR
    RADER, DJ
    BREWER, HB
    CIRCULATION, 1990, 82 (04) : 425 - 425
  • [4] BINDING OF HUMAN APOLIPOPROTEIN A-IV TO HUMAN HEPATOCELLULAR PLASMA-MEMBRANES
    WEINBERG, RB
    PATTON, C
    ARTERIOSCLEROSIS, 1988, 8 (05): : A609 - A609
  • [5] HUMAN APOLIPOPROTEIN A-IV - INTESTINAL ORIGIN
    GREEN, PHR
    GLICKMAN, RM
    RILEY, JW
    QUINET, E
    GASTROENTEROLOGY, 1979, 76 (05) : 1143 - 1143
  • [6] Activation of human plasma cholesteryl ester transfer protein by human apolipoprotein A-IV
    Main, LA
    Ohnishi, T
    Yokoyama, S
    BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1300 (01): : 17 - 24
  • [7] APOLIPOPROTEIN HOMOLOG OF RAT APOLIPOPROTEIN A-IV IN HUMAN-PLASMA - ISOLATION AND PARTIAL CHARACTERIZATION
    BEISIEGEL, U
    UTERMANN, G
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1979, 93 (03): : 601 - 608
  • [8] PLASMA IGG AND APOLIPOPROTEIN A-IV (APO A-IV) LEVELS IN RATS FOLLOWING THE INJECTION OF ADJUVANT
    RODRIGUEZ, MD
    BOYKEN, VK
    WOLF, RE
    TSO, P
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 561 - 561
  • [9] Human apolipoprotein A-IV metabolism within triglyceride-rich lipoproteins and plasma
    Sun, ZY
    Lichtenstein, AH
    Dolnikowski, GG
    Welty, FK
    Schaefer, EJ
    ATHEROSCLEROSIS, 2001, 156 (02) : 363 - 372
  • [10] Severe experimental colitis in apolipoprotein A-IV knockout mice can be prevented with recombinant human apolipoprotein A-IV treatment
    Vowinkel, T
    Kalogeris, TJ
    Krieglstein, CF
    Mori, M
    Turnage, RH
    Tso, P
    Granger, DN
    GASTROENTEROLOGY, 2004, 126 (04) : A283 - A283